Last reviewed · How we verify
normobaric oxygen with face mask — Competitive Intelligence Brief
phase 3
Oxygen therapy / Medical gas
Respiratory / Critical Care / Multiple therapeutic areas
Small molecule
Live · refreshed every 30 min
Target snapshot
normobaric oxygen with face mask (normobaric oxygen with face mask) — Shahid Beheshti University of Medical Sciences. Normobaric oxygen therapy increases arterial oxygen partial pressure to enhance tissue oxygenation and reduce hypoxia-related pathology.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| normobaric oxygen with face mask TARGET | normobaric oxygen with face mask | Shahid Beheshti University of Medical Sciences | phase 3 | Oxygen therapy / Medical gas |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape (Oxygen therapy / Medical gas class)
- Shahid Beheshti University of Medical Sciences · 1 drug in this class
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- normobaric oxygen with face mask CI watch — RSS
- normobaric oxygen with face mask CI watch — Atom
- normobaric oxygen with face mask CI watch — JSON
- normobaric oxygen with face mask alone — RSS
- Whole Oxygen therapy / Medical gas class — RSS
Cite this brief
Drug Landscape (2026). normobaric oxygen with face mask — Competitive Intelligence Brief. https://druglandscape.com/ci/normobaric-oxygen-with-face-mask. Accessed 2026-06-09.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing